Results 11 to 20 of about 1,626 (189)
Effects of Ramosetron on Gastrointestinal Transit of Guinea Pig [PDF]
Journal of Neurogastroenterology and Motility, 2013 A selective 5-hydroxytryptamine (5-HT) type 3 receptor antagonist, ramosetron, inhibits stress-induced abnormal defecation in animals and is currently used as a therapeutic drug for irritable bowel syndrome with diarrhea. The aim of this study is to investigate the effect of ramosetron on altered gastrointestinal (GI) transit.Male guinea pigs weighing ...
Park, Yoo Mi +4 more
openaire +5 more sources
Prevention of microemulsion propofol injection pain: a comparison of a combination of lidocaine and ramosetron with lidocaine or ramosetron alone [PDF]
Korean Journal of Anesthesiology, 2011 BackgroundA microemulsion propofol causes a high incidence of pain during intravenous injection. In this study, we investigated the effect of ramosetron on pain induced by microemulsion propofol injection.MethodsAfter prospective power analysis and ...
Hyun-Young Lee +2 more
doaj +3 more sources
Efficacy of ramosetron in combination with polyethylene glycol of preparing for a colonoscopy [PDF]
Yeungnam University Journal of Medicine, 2019 Background Because of its efficacy and safety, polyethylene glycol (PEG) is generally used to prepare for colonoscopy. However, the side effects of PEG, including nausea, vomiting, abdominal discomfort, pain, and general weakness, tend to decrease ...
Min Kyu Kang +3 more
doaj +4 more sources
PLoS ONE, 2016 Previous randomized controlled trials have reported conflicting findings on the superiority of palonosetron over ramosetron for preventing postoperative nausea and vomiting (PONV).
EunJin Ahn +7 more
doaj +2 more sources
Efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery [PDF]
Korean Journal of Anesthesiology, 2012 BackgroundOpioid-based patient controlled analgesia (PCA) provides adequate pain control following spinal surgeries at the expense of increased risk of postoperative nausea and vomiting (PONV).
So-Young Yang +6 more
doaj +3 more sources
Indian Journal of Anaesthesia, 2015 Background and Aims: Post-operative nausea and vomiting (PONV) has an 80% incidence in high-risk patients. This is despite the availability of several antiemetic drugs.
Sandip Agarkar, Aparna S Chatterjee
doaj +2 more sources
Therapeutic Advances in Gastroenterology, 2015 Irritable bowel syndrome (IBS) is a highly prevalent functional bowel disorder. Serotonin (5-HT) is known to play a physiological and pathophysiological role in the regulation of gastrointestinal function.
Yang Won Min, Poong-Lyul Rhee
doaj +2 more sources
BMC Gastroenterology, 2018 Background Ramosetron is a potent and selective serotonin type 3 receptor antagonist. This meta-analysis aimed to analyze the efficacy and safety of ramosetron for irritable bowel syndrome with diarrhea (IBS-D).
Qingqing Qi +4 more
doaj +2 more sources
Drug Design, Development and Therapy, 2015 Chengjie Gao, Bo Li, Lufeng Xu, Fubin Lv, Guimao Cao, Huixia Wang, Fei Wang, Guanghan WuDepartment of Anesthesiology, General Hospital of Jinan Military Command, Jinan, People’s Republic of ChinaBackground: Postoperative nausea and vomiting is
Gao CJ +7 more
doaj +1 more source
Clinical and Experimental Gastroenterology, 2013 Toshimi Chiba, Kazunari Yamamoto, Shoko Sato, Kazuyuki Suzuki Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Iwate, Japan Abstract: Irritable bowel syndrome (IBS) is a ...
Chiba T, Yamamoto K, Sato S, Suzuki K
doaj +1 more source